Drugdiscovery >> Drug Development >> News
6826
Views
Novartis' Serelaxin is a breakthrough in heart drug development - drugdiscovery.com
Novartis' Serelaxin is a breakthrough in heart drug development - drugdiscovery.com


Novartis have given breakthrough therapy status by FDA to an investigational treatment for patients with acute heart failure.
Read More >>


Tags: heart failure,drug,Serelaxin - July 15, 2013
Related Articles
1311
Views
Heart drug of novertis was rejected by FDA Heart drug of novertis was rejected by FDA
Cardiovascular and Renal Drugs Advisory Committee has rejected a new heart drug of Novartis. Serelaxin was not apporved due to lack of data. Read More >>

Tags: Serelaxin, heart failure, cardiovascular disease, novartis, FDA, FDA rejection

2624
Views
Novartis looks forward to have its new drug accepted in the EU Novartis looks forward to have its new drug accepted in the EU
Novartis has announced that it has submitted the revised service pack of Serelaxin to Committee for Medicinal Products for Human Use (CHMP). This drug is used in case of chronic heart failure. Read More >>

Tags: chronic heart failure, Committee for Medicinal Products for Human Use, Serelaxin

6068
Views
Glucose-lowering drugs might have effects on heart Glucose-lowering drugs might have effects on heart
One of the most common reason of being hospitalized because opf heart failure is diabetes - according to the data. Scientist say, the hear-risk effect of glucose lowering drugs are often overlooked on Read More >>

Tags: clinical trial, diabetes, gluvose-lowering drug, effect, heart, heart attack, heart failure

1099
Views
Side Effects free heart attack drug was unlocked Side Effects free heart attack drug was unlocked
Melbourne based scientists have taken a big step towards a drug, which can reduce the damage made by a heart attack significantly. The new discovery is unique since the drug does not have any of the w Read More >>

Tags: heart attack, heart attack damage, heart failure

2895
Views
Breakthrough in cancer research – Rational, personalized combination therapy against cancer driver genes Breakthrough in cancer research – Rational, personalized combination therapy against cancer driver genes
There is a breakthrough now in cancer research and therapy providing personalized targeted drug combinations for cancer patients to treat the disease and overcome primary and secondary resistance due Read More >>

Tags: cancer drugs, cancer research, DriverHit Library, drug development, genes

1171
Views
New drug of Novartis and Lilly was successful in trials New drug of Novartis and Lilly was successful in trials
Phase III REVEL study data say that the new drug of Novartis and Lilly is effective in metastatic non-small cell lung cancer cases. Ramucirumab showed very good results in clinical tests. Read More >>

Tags: Ramucirumab, chemotherapy, cancer, Lilly, Novartis

3388
Views
Multiple Myeloma drug of Novartis is promising Multiple Myeloma drug of Novartis is promising
Multiple myeloma drug on Novartis prooved to be effective in Phase III trials. Panobinostat in combination with bortezomib and dexamethasone seems to be more effecite than bortezomib plus dexamethaso Read More >>

Tags: bortezomib, dexamethasone, myeloma, Novartis

4245
Views
Fabricated Data in Novartis Drug Trial Fabricated Data in Novartis Drug Trial
Japanese minister confirms that data from a large Japanese study was fabricated. Read More >>

Tags: Novartis, Diovan, drug trial

7843
Views
SOLIAIR™ - Breathing Made Easy! SOLIAIR™ - Breathing Made Easy!
SOLIAIR™ is a blend of botanical extracts and a food supplement that can help patients in chronic respiratory diseases such as Asthma, Bronchitis, COPD and other respiratory infections! Read More >>

Tags: Drug Development,Drug Discovery,Medicine Development,COPD Treatment,Asthma Solution,Bronchitis Therapy,Respiratory Diseases,Lung Infections,Breathing Disorders,healthcare investment,Drug Innovation,

11031
Views
New Pulmonary and Lung Diseases Solution! New Pulmonary and Lung Diseases Solution!
SOLIAIR™ is a food supplement which has reported beneficial impact. SOLIAIR™ can contribute to strengthening the respiratory system and may help patients in chronic respiratory diseases! Read More >>

Tags: Drug Development,Drug Discovery,Medicine Development,COPD Treatment,Asthma Solution,Bronchitis Therapy,Respiratory Diseases,Lung Infections,Breathing Disorders,healthcare investment,Drug Innovation,

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013